文章摘要
贺宇彤,梁迪,李道娟,翟京波,刘波,朱俊卿,单保恩.河北省2011年恶性肿瘤发病与死亡分析[J].中华流行病学杂志,2015,36(8):846-851
河北省2011年恶性肿瘤发病与死亡分析
Incidence and mortality of cancers appeared in the Hebei provincial cancer registry system in 2011
收稿日期:2015-01-15  出版日期:2015-08-11
DOI:10.3760/cma.j.issn.0254-6450.2015.08.017
中文关键词: 恶性肿瘤  发病率  死亡率
英文关键词: Malignant tumor  Incidence  Mortality
基金项目:国家自然科学基金(81272682)
作者单位E-mail
贺宇彤 050011 石家庄, 河北医科大学第四医院肿瘤研究所  
梁迪 050011 石家庄, 河北医科大学第四医院肿瘤研究所  
李道娟 050011 石家庄, 河北医科大学第四医院肿瘤研究所  
翟京波 河北省卫生厅疾病控制处  
刘波 河北省卫生厅疾病控制处  
朱俊卿 河北省卫生厅疾病控制处  
单保恩 050011 石家庄, 河北医科大学第四医院肿瘤研究所 baoenshan@hbydsy.com 
摘要点击次数: 3353
全文下载次数: 1851
中文摘要:
      目的 评估2011年河北省肿瘤登记地区恶性肿瘤发病与死亡。方法 收集2011年河北省8个肿瘤登记地区上报的恶性肿瘤发病与死亡资料, 计算恶性肿瘤发病率、死亡率、前10位恶性肿瘤顺位、构成、累积率;采用2000年中国标化人口构成和Segi's世界人口构成分别计算中国和世界人口年龄标化发病/死亡率(中标率和世标率)。结果 2011年河北省8个肿瘤登记地区共覆盖人口4 573 293人(其中城市2 139 779人, 农村2 433 514人), 恶性肿瘤新发病例11 269例, 死亡病例7 477例。恶性肿瘤病理诊断比例为75.26%, 只有死亡证明书比例为3.85%, 死亡发病比为0.66。全部恶性肿瘤发病率为246.41/10万(男性264.55/10万, 女性227.75/10万), 中标率为207.13/10万, 世标率为206.61/10万, 累积率(0~74岁人群)为23.57%。城市地区发病率为242.64/10万, 中标率为200.19/10万;农村地区发病率为249.72/10万, 中标率为214.11/10万。全部恶性肿瘤死亡率为163.49/10万(男性196.54/10万, 女性129.51/10万), 中标率为144.48/10万, 世标率为147.69/10万, 累积率(0~74岁人群)为14.71%。农村地区死亡率(167.91/10万)高于城市地区死亡率(158.47/10万)。胃癌、肺癌、食管癌、乳腺癌、肝癌、结直肠癌是河北省常见的恶性肿瘤, 约占全部新发病例的71.66%。肺癌、胃癌、食管癌、肝癌和结直肠癌是威胁河北省居民生命健康的主要恶性肿瘤, 约占死亡病例的74.79%。结论 2011年河北省肿瘤登记地区主要恶性肿瘤为胃癌、肺癌、食管癌、乳腺癌、肝癌、结直肠癌。
英文摘要:
      Objective To analyze the cancer incidence and mortality in Hebei cancer registry available areas in 2011. Methods Data were collected from 8 population-based cancer registries systems in Hebei province. Incidence and mortality rates stratified by areas (urban/rural), sex, age group and cancer site were analyzed. 10 common cancers in different groups, proportions and cumulative rates were calculated. The Chinese population census in the year 2000 and Segi's populations were used for age-standardized incidence/mortality rates. Results In all the 8 cancer registries that covering a total of 4 573 293 population (2 139 779 in urban and 2 433 514 in rural areas), data was used for the analysis. The total new cancer incidence cases and deaths were 11 269 and 7 477, respectively. All the morphologically verified cancer cases (MV%) accounted for 75.26% while 3.85% of the incident cases were identified only through death certification records (DCO%). The mortality to incidence ratio appeared as 0.66. The crude incidence appeared in the Hebei cancer registration areas was 246.41/105(264.55/105 in males and 227.75/105 in females). The age-standardized incidence rates by Chinese standard population (ASIRC) and by world standard population(ASIRW) appeared as 207.13/105 and 206.61/105 respectively, with the cumulative incidence rates as (0-74 age years old) 23.57%. The cancer incidence and ASIRC were 242.64/105 and 200.19/105 in urban areas, whereas 249.72/105 and 214.11/105, respectively in rural areas. The crude mortality in Hebei cancer registration areas was 163.49/105(196.54/105 in male, 129.51/105 in female), with age-standardized mortality rates by Chinese standard population (ASMRC) and by world standard population (ASMRW) as 144.48/105 and 147.69/105. The cumulative mortality rate (0-74 age years old) was 14.71%. The cancer mortality (167.91/105) in rural areas seemed higher than the mortality (158.47/105) in urban areas. The most common sites of cancers were: stomach, lung, esophagus, breast, liver and colorectal, which accounted for 71.66% of all the cancer cases. Lung cancer, stomach cancer, esophagus cancer, liver cancer and colorectal cancer were the major causes responsible for the cancer deaths in the areas with data of cancer registration, which accounted for 74.79% of all the cancer deaths. Conclusion The coverage of Hebei cancer registration population could reflect the cancer burden in various areas and populations. The most commonly seen cancers were stomach, lung, esophagus, breast, liver, and colorectal, in Hebei province. In order to reduce the burden of cancers, prevention and control measures should be strengthened.
查看全文   Html全文     查看/发表评论  下载PDF阅读器
关闭